Renovorx, INC. (RNXT) SEC Filings — 2024
19 SEC filings for Renovorx, INC. (RNXT) in 2024.
Filings
- RenovoRx Files 8-K on Financials — 8-K · Nov 14, 2024
- RenovoRx Files Q3 2024 10-Q Report — 10-Q · Nov 13, 2024
- RenovoRx Files 8-K: Procedural Update — 8-K · Sep 25, 2024
- RenovoRx Dismisses Auditor BDO USA, LLP — 8-K · Aug 16, 2024
- RenovoRx Files Q2 2024 10-Q — 10-Q · Aug 13, 2024
- RenovoRx Appoints Dr. Jonathan Lim to Board — 8-K · Jun 7, 2024
- RenovoRx, Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 10, 2024
- RenovoRx Changes Auditors — 8-K · May 3, 2024
- RenovoRx, Inc. Schedules 2024 Annual Meeting of Stockholders — DEF 14A · Apr 30, 2024
- RenovoRx Prices $1.5M Registered Direct Offering — 8-K · Apr 18, 2024
- RenovoRx, Inc. Files 8-K Report — 8-K · Apr 16, 2024
- RenovoRx Sells $1M in Stock — 8-K · Apr 15, 2024
- RenovoRx, Inc. Files 8-K: Material Agreement & Other Events — 8-K · Apr 9, 2024
- RenovoRx, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Apr 1, 2024
- RenovoRx Appoints Biotech Veteran Rothberg to Board — 8-K · Mar 14, 2024
- RenovoRx Faces Nasdaq Delisting, Appoints New CEO — 8-K · Feb 23, 2024
- RenovoRx Director James Ahlers Resigns from Board, Committees — 8-K · Feb 9, 2024
- RenovoRx Files 8-K: Material Agreement & Officer Compensation Changes — 8-K · Jan 29, 2024
- RenovoRx Opts Out of EGC Accounting Transition Period — 8-K · Jan 2, 2024